Faeth Therapeutics, Inc. SEC filings FTH
Faeth Therapeutics, Inc. has 452 filings in SEC EDGAR's recent list, going back to Nov 12, 2020. Its latest annual report, Form ARS, was filed on Apr 27, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Results of operations
|
Nov 3, 2026 | Nov 3, 2026 |
| 8-K |
Current report
Officer or director change
|
Oct 27, 2026 | Oct 23, 2026 |
| 8-K |
Current report
Officer or director change
|
Sep 17, 2026 | Sep 11, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2026 | Aug 4, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 23, 2026 | Jul 21, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jun 18, 2026 | Jun 15, 2026 |
| 8-K |
Current report
Agreement ended, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure, Other events
|
Jun 15, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 10, 2026 | Jun 10, 2026 |
| 8-K |
Current report
Other events
|
May 22, 2026 | May 22, 2026 |
| 8-K |
Current report
Other events
|
May 21, 2026 | May 21, 2026 |
| 8-K |
Current report
Results of operations
|
May 15, 2026 | May 15, 2026 |
| 8-K |
Current report
Officer or director change
|
Apr 16, 2026 | Apr 10, 2026 |
| 8-K/A | Amended current report | Apr 15, 2026 | Feb 17, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 30, 2026 | Mar 30, 2026 |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Unregistered share sale, Officer or director change, Bylaw or fiscal year change, Regulation FD disclosure
|
Feb 18, 2026 | Feb 17, 2026 |
| 8-K |
Current report
Officer or director change
|
Feb 13, 2026 | Feb 13, 2026 |
| 8-K |
Current report
Officer or director change
|
Dec 23, 2025 | Dec 22, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2025 | Nov 14, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 30, 2025 | Oct 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 17, 2025 | Oct 17, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2025 | Aug 5, 2025 |
| 8-K |
Current report
Listing notice
|
Jul 9, 2025 | Jul 2, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 13, 2025 | Jun 12, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 23, 2025 | May 21, 2025 |
| 8-K |
Current report
Results of operations
|
May 6, 2025 | May 6, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2025 | Mar 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 27, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Listing notice
|
Jan 7, 2025 | Jan 7, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2024 | Nov 14, 2024 |
| 8-K |
Current report
Officer or director change
|
Oct 30, 2024 | Oct 25, 2024 |
| 8-K |
Current report
Officer or director change
|
Sep 20, 2024 | Sep 17, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2024 | Aug 6, 2024 |
| 8-K |
Current report
Listing notice
|
Jul 12, 2024 | Jul 10, 2024 |
| 8-K |
Current report
Officer or director change
|
Jun 27, 2024 | Jun 26, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 13, 2024 | Jun 11, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 3, 2024 | Jun 3, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 23, 2024 | May 23, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 12, 2024 | Apr 11, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 2, 2024 | Mar 27, 2024 |
| 8-K |
Current report
Material agreement, Change to shareholder rights
|
Mar 5, 2024 | Mar 5, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2024 | Feb 28, 2024 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 8, 2024 | Feb 5, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 4, 2024 | Jan 4, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2023 | Nov 7, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 6, 2023 | Nov 6, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 3, 2023 | Nov 3, 2023 |
| 8-K |
Current report
Listing notice
|
Oct 20, 2023 | Oct 17, 2023 |
| 8-K |
Current report
Results of operations
|
Aug 3, 2023 | Aug 3, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jul 10, 2023 | Jul 10, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 27, 2023 | Jun 27, 2023 |
| 8-K |
Current report
Material agreement, Change to shareholder rights
|
Jun 23, 2023 | Jun 23, 2023 |
| 8-K |
Current report
Material agreement
|
May 23, 2023 | May 23, 2023 |
| 8-K |
Current report
Results of operations
|
May 9, 2023 | May 9, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 20, 2023 | Apr 20, 2023 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2023 | Mar 28, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 13, 2023 | Mar 13, 2023 |
| 8-K |
Current report
Other events
|
Mar 10, 2023 | Mar 10, 2023 |
| 8-K |
Current report
Material agreement, Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Mar 7, 2023 | Mar 7, 2023 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 6, 2023 | Jan 31, 2023 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 9, 2022 | Dec 5, 2022 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change, Regulation FD disclosure
|
Dec 8, 2022 | Dec 5, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Nov 8, 2022 | Nov 8, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 30, 2022 | Sep 30, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 31, 2022 | Aug 31, 2022 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 9, 2022 | Aug 9, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2022 | Jun 10, 2022 |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 20, 2022 | Apr 20, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2022 | Mar 10, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Mar 9, 2022 | Mar 8, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 10, 2022 | Jan 10, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Dec 6, 2021 | Dec 6, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Nov 16, 2021 | Nov 16, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2021 | Nov 9, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 8, 2021 | Sep 8, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 4, 2021 | Aug 4, 2021 |
| 8-K |
Current report
Officer or director change
|
Aug 2, 2021 | Jul 30, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 28, 2021 | Jun 28, 2021 |
| 8-K |
Current report
Officer or director change
|
Jun 17, 2021 | Jun 11, 2021 |
| 8-K |
Current report
Results of operations
|
May 12, 2021 | May 12, 2021 |
| 8-K |
Current report
Officer or director change
|
May 3, 2021 | Apr 28, 2021 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 5, 2021 | Apr 1, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 25, 2021 | Mar 25, 2021 |
| 8-K |
Current report
Bylaw or fiscal year change, Other events
|
Feb 11, 2021 | Feb 8, 2021 |
Showing 86 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- FTH (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Austin, TX
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1829802
- Former names
- Sensei Biotherapeutics, Inc. (until Jun 16, 2026)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.